開能健康(300272.SZ):創始人瞿建國重新成為實控人
格隆匯4月13日丨 開能健康(300272.SZ)公佈,2020年4月10日,公司接到公司控股股東鈞天(寧夏)投資管理中心(有限合夥)(以下簡稱"鈞天投資")與公司實際控制人趙笠鈞的通知,鈞天投資與瞿建國於2020年4月10日簽署了《關於開能健康科技集團股份有限公司之表決權委託終止協議》(以下簡稱《終止協議》),雙方同意瞿建國將其持有的公司股份6634.08萬股(約佔目前公司總股本的11.38%)項下的表決權委託期限於該協議簽署之日終止。此外,2020年4月10日,瞿建國還簽署了《關於放棄表決權的承諾函》。
此次權益變動後,瞿建國持有的開能健康11.38%的表決權原委託鈞天投資行使,現在終止委託;同時,瞿建國另行放棄其持有的公司2.31%股份表決權。瞿建國和一致行動人合計可支配公司股份表決權由20.52%增至29.59%。瞿建國成為上市公司的控股股東、實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.